These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4464520)

  • 1. Treatment of blepharospasm with levodopa.
    Chakravorty NK
    Postgrad Med J; 1974 Aug; 50(586):521-23. PubMed ID: 4464520
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of blepharospasm-oromandibular dystonia syndrome.
    Casey DE
    Neurology; 1980 Jul; 30(7 Pt 1):690-5. PubMed ID: 7190236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease.
    Ramírez-Gómez CC; Zúñiga-Ramírez C; Contartese ML; Montilla V; Gramajo J; Micheli F
    Clin Neuropharmacol; 2019; 42(1):14-16. PubMed ID: 30649026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meige disease: striatal dopaminergic preponderance.
    Tolosa ES; Lai C
    Neurology; 1979 Aug; 29(8):1126-30. PubMed ID: 379689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
    Kurtis MM; Franch O
    Parkinsonism Relat Disord; 2011 Dec; 17(10):774-6. PubMed ID: 21733737
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
    Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A
    Funct Neurol; 1988; 3(4):471-9. PubMed ID: 3072281
    [No Abstract]   [Full Text] [Related]  

  • 7. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole Can Improve Apraxia of Eyelid Opening in Parkinson's Disease.
    Tokisato K; Fukunaga K; Tokunaga M; Watanabe S; Nakanishi R; Yamanaga H
    Intern Med; 2015; 54(23):3061-4. PubMed ID: 26631893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics.
    Nutt JG
    Ann Neurol; 1987 Oct; 22(4):535-40. PubMed ID: 3324948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy (report of 4 cases with particular reference to blepharospasm and levodopa therapy).
    Singh S; Smith BH; Lal A
    Neurol India; 1974 Jun; 22(2):65-71. PubMed ID: 4437701
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of benign essential blepharospasm with finasteride: a case report.
    Bortolato M; Cannas A; Solla P; Puligheddu M; Muroni A; Marrosu F
    Clin Neuropharmacol; 2010 Jul; 33(4):207-8. PubMed ID: 20386102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease dyskinesias.
    Nutt JG; Gancher ST
    Neurology; 1994 Jun; 44(6):1187; author reply 1187-8. PubMed ID: 8208427
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of botulinum in the treatment of 100 patients with blepharospasm.
    Mauriello JA; Coniaris H
    N J Med; 1987 Jan; 84(1):43-4. PubMed ID: 3472105
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of blepharospasm with botulinum A toxin.
    Kim YD; Levine MR
    Korean J Ophthalmol; 1987 Dec; 1(2):102-8. PubMed ID: 3508221
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of benign essential blepharospasm with cyproheptadine.
    Fasanella RM; Aghajanian GK
    N Engl J Med; 1990 Mar; 322(11):778. PubMed ID: 2308610
    [No Abstract]   [Full Text] [Related]  

  • 16. Motor response complications in advanced Parkinson's disease.
    Chase TN; Juncos JL; Fabbrini G; Mouradian MM
    Funct Neurol; 1988; 3(4):429-36. PubMed ID: 3072278
    [No Abstract]   [Full Text] [Related]  

  • 17. Blepharospasm: successful treatment with clonazepam.
    Merikangas JR; Reynolds CF
    Ann Neurol; 1979 Apr; 5(4):401-2. PubMed ID: 443775
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Martinez-Lage JM
    Funct Neurol; 1988; 3(4):413-27. PubMed ID: 3072277
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopa-responsive camptocormia in a patient with multiple system atrophy.
    Song IU; Kim JS; Lee KS
    Parkinsonism Relat Disord; 2008; 14(2):161-3. PubMed ID: 17433754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of blepharospasm with botulinum A toxin injections].
    Bihari K
    Orv Hetil; 1988 Jan; 129(2):67-8. PubMed ID: 3344134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.